 Navidea Biopharmaceuticals, Inc. NYSE:NAVB Q3 2022 Earnings Conference Call November 15, 2022 5:00 PM ET Company Participants Michael Rosol Chief Medical Officer Erika Eves Vice President-Finance and Administration Conference Call Participants Michael Okunewitch Maxim Group Mike Rigali Private Investor Operator Greetings and welcome to the Navidea Biopharmaceuticals Quarter Three Earnings Call and Business Update. Operator Instructions And as a reminder this conference call is being recorded. 